Phathom Pharmaceuticals, Inc.
Nasdaq PHAT · Florham Park, NJ
Works in GI & liver · Hematology · Immunology
Phathom Pharmaceuticals, Inc. is a clinical trial sponsor based in Florham Park, NJ, listed as Nasdaq PHAT. It has 3 active clinical trials with 1,323 planned participants, in GI & liver, Hematology and Immunology. Since 2021 it has completed 11 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq PHAT
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
4 approved drug applications with a product on the market.
Questions about Phathom Pharmaceuticals, Inc
Phathom Pharmaceuticals, Inc is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 1,323 planned participants, in GI & liver, Hematology, Immunology. Since 2021 it has completed 11 trials and stopped 1 early.
Phathom Pharmaceuticals, Inc is based in Florham Park, NJ and is listed as Nasdaq PHAT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Phathom Pharmaceuticals, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-13.
Approve Suite is not affiliated with Phathom Pharmaceuticals, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.